Rallybio Corporation announced that it has appointed Wendy K. Chung, M.D., Ph.D., to its Board of Directors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | -2.15% | -1.09% | -24.27% |
May. 15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
May. 09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.27% | 77.1M | |
+33.44% | 50.85B | |
+0.79% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.93% | 26.11B | |
-21.66% | 19.13B | |
+9.15% | 13.05B | |
+27.06% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- Rallybio Corporation Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors